Skip to content

BioFlo Vortex CT60LPBDNFVIRecalls & reported problems

Navilyst Medical, Inc. · SmartPort+ Low Profile with Endexo and Vortex Technology · Class 2 · Implant

All models of BioFlo Vortex (5)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI H787CT60LPBDNFVI0), received between Feb 17, 2022 and Feb 17, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Fracture1

Patient problems

  • Device Embedded In Tissue or Plaque1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 17, 2022Fracture; Fracture

    AN END USER REPORTED AN ISSUE WITH A 6F LOW PROFILE PLASTIC VORTEX PORT. IT WAS REPORTED THAT THE PORT SEPARATED INTERNALLY, REQUIRING REMOVAL AND REPLACEMENT. NO ADDITIONAL INFORMATION WAS REPORTED.

    Patient problems: Device Embedded In Tissue or Plaque

    MAUDE report 13549906 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page